AbbVie Inc. (TSX:ABBV)

AbbVie Revenue

AbbVie had revenue of $17.40B USD in the quarter ending September 30, 2026, with 10.32% growth. This brings the company's total for the last twelve months to $66.01B, up 10.68% year-over-year. In the year 2025, AbbVie had annual revenue of $61.16B with 8.57% growth.

• Revenue (ttm): $66.01B
• Revenue Growth: +10.68%
• P/S Ratio: 7.76
• Revenue / Employee: $1.16M
• Employees: 57,000
• Market Cap: 727.09B CAD

Revenue Chart

Chart

Chart

* This company reports financials in USD.

Revenue by Segment

By Segment

Chart

• Immunology 30.41B 49.7%
• Neuroscience 10.77B 17.6%
• Oncology 6.66B 10.9%
• Aesthetics 4.86B 7.9%
• Other Key Products 3.74B 6.1%
• All Other 2.63B 4.3%
• Eye Care 2.11B 3.4%

By Geography

Chart

• United States 46.60B 76.2%
• International 14.56B 23.8%

Fiscal year ended Dec 31, 2025 See the full AbbVie breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	61.16B	4.83B	8.57%
Dec 31, 2024	56.33B	2.02B	3.71%
Dec 31, 2023	54.32B	-3.74B	-6.44%
Dec 31, 2022	58.05B	1.86B	3.30%
Dec 31, 2021	56.20B	10.39B	22.69%
Dec 31, 2020	45.80B	12.54B	37.69%
Dec 31, 2019	33.27B	513.00M	1.57%
Dec 31, 2018	32.75B	4.54B	16.08%
Dec 31, 2017	28.22B	2.58B	10.06%
Dec 31, 2016	25.64B	2.78B	12.16%
Dec 31, 2015	22.86B	2.90B	14.52%
Dec 31, 2014	19.96B	1.17B	6.23%
Dec 31, 2013	18.79B	410.00M	2.23%
Dec 31, 2012	18.38B	936.00M	5.37%
Dec 31, 2011	17.44B	1.81B	11.55%
Dec 31, 2010	15.64B	1.42B	10.02%
Dec 31, 2009	14.21B	-	-

Data Source: Fiscal.ai Last updated: Sep 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 1, 2026

Data Sources Report a data error